Showing 1 - 4 results of 4 for search 'David Stenehjem' Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Author
  • David Stenehjem
Showing 1 - 4 results of 4 for search 'David Stenehjem', query time: 0.04s Refine Results
  1. 1
    Fatal Statin-Induced Rhabdomyolysis by Possible Interaction with Palbociclib
    Fatal Statin-Induced Rhabdomyolysis by Possible Interaction with Palbociclib
    by Kellie Lynn Nelson, David Stenehjem, Meghan Driscoll, Meghan Driscoll, Glynn Weldon Gilcrease, Glynn Weldon Gilcrease
    Published 2017-07-01
    Get full text
    Article
  2. 2
    Estimation of healthcare‐related charges in women with BRCA mutations and breast cancer
    Estimation of healthcare‐related charges in women with BRCA mutations and breast cancer
    by Joseph Biskupiak, Sudhir Unni, Claire Telford, Minkyoung Yoo, Xiangyang Ye, Rishi Deka, Diana Brixner, David Stenehjem
    Published 2021-01-01
    Get full text
    Article
  3. 3
    Real-world progression-free survival in first-line advanced non-small cell lung cancer treated with immunotherapy-based regimens using a US dataset
    Real-world progression-free survival in first-line advanced non-small cell lung cancer treated with immunotherapy-based regimens using a US dataset
    by David Waterhouse, Jenny Lam, Keith A. Betts, Lei Yin, Sophie Gao, Yong Yuan, John Hartman, Sumati Rao, Solomon Lubinga, David Stenehjem
    Published 2021-08-01
    Get full text
    Article
  4. 4
    Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online
    Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests Oncot...
    by Beate Jahn, Ursula Rochau, Christina Kurzthaler, Michael Hubalek, Rebecca Miksad, Gaby Sroczynski, Mike Paulden, Marvin Bundo, David Stenehjem, Diana Brixner, Murray Krahn, Uwe Siebert
    Published 2017-10-01
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...